Biomarker analysis of patients with follicular lymphoma treated with ibrutinib in the phase 2 DAWN study
Fowler, N., Gopal, A.K., Schuster, S.J., Trotman, J., Hess, G., Hou, J., Yacoub, A., Lill, M., Martin, P., Vitolo, U., Spencer, A., Radford, J., Jurczak, W., Morton, J., Osmanov, D., Caballero, D., DeVolume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_75
Date:
June, 2017
File:
PDF, 295 KB
english, 2017